WHO ICTRP trial
Comparison of intravenous tranexamic acid and intravenous fibrinogen on bleeding…
IRCT20210415050983N4 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20210415050983N4 |
|---|---|
| Public title | Comparison of intravenous tranexamic acid and intravenous fibrinogen on bleeding control in posterior lumbar spine fusion surgery. |
| Scientific title | Comparison of intravenous tranexamic acid and intravenous fibrinogen on bleeding control in posterior lumbar spine fusion surgery. |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Lumbar Discopathy. Intervertebral disc disorders with myelopathy, thoracolumbar region;M51.05 |
| Interventions | Intervention 1: The group receiving tranexamic acid: 15-30 minutes before surgical incision, 15mg/kg tranexamic acid, which has been diluted with normal saline to a volume of 20 cc, will be administered intravenously. Intervention 2… |
| Registration date | Mar 6, 2023 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: